AI assistant
SOLENO THERAPEUTICS INC — Director's Dealing 2023
May 26, 2023
31377_dirs_2023-05-26_1450c696-7c62-4e37-8f95-04f0e8cc52e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLENO THERAPEUTICS INC (SLNO)
CIK: 0001484565
Period of Report: 2023-05-26
Reporting Person: Hirano Patricia C (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-05-26 | Common Stock | A | 28149 | $0.00 | Acquired | 37422 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-26 | Employee stock option (right to buy) | $5.25 | A | 84448 | Acquired | 2033-05-26 | Common Stock (84448) | Direct |
Footnotes
F1: These securities are restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs shall vest on November 26, 2023, subject to the Reporting Person continuing to be a Service Provider through such date.
F2: Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.
F3: One thirty-sixth of the shares subject to the Option shall vest on June 26, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date.